CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [Phase 4]
Summary
Phase 4 clinical trial update for tirzepatide (LY3298176) in adults with Type 2 diabetes during Ramadan, currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING